The Macfarlane Burnet Institute for Medical Research and Public Health
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hellard, Margaret
CUTTS HepC, NCT06159504: Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania

Not yet recruiting
1
3040
NA
sofosbuvir/velpatasvir (SOF/VEL), Shortened read time of rapid diagnostic test for hepatitis C virus., OraQuick® HCV RDT
Médecins du Monde, UNITAID, Burnet Institute, University of Bristol, International Network of People who Use Drugs
Hepatitis C, RDT
12/26
12/26
NCT04061551: Eliminate Hepatitis C/EC Partnership Evaluation Protocol

Recruiting
N/A
25
RoW
EC clinic support - whole of practice interventions delivery through nurse-led model
Macfarlane Burnet Institute for Medical Research and Public Health Ltd, Burnet Institute, The Alfred, St Vincent's Hospital Melbourne, HepatitisVictoria, Harm Reduction Australia, Victoria State Government, Gilead Sciences, National Health and Medical Research Council, Australia
Hepatitis C, Chronic Hepatitis c, Hepatitis C, Chronic
12/21
12/21
NCT05323799: The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise)

Active, not recruiting
N/A
1000
RoW
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
COVID-19
06/24
06/24

Download Options